Treats obsessions and compulsions. ANDA 75902, held by Apotex. Fluvoxamine Maleate.
As of Nov 16, 2026, ANDA 75902 (Fluvoxamine Maleate), held by Apotex, was first approved by FDA on May 7, 2001, with 18 approved supplements and 0 published complete response letters.
Fluvoxamine maleate tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD). 1.1 Obsessive-Compulsive Disorder
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 7, 2001 | Original application | Approved |
| Fluvoxamine Maleate25MG · tablet;oral | Fluvoxamine Maleate | Rx |
| Fluvoxamine Maleate50MG · tablet;oral | Fluvoxamine Maleate | Rx |
| Fluvoxamine Maleate100MG · tablet;oral | Fluvoxamine Maleate | Rx |
| Nov 27, 2023 | Supplement 29Labeling · Standard review | Approved | None posted |
| Dec 19, 2022 | Supplement 26Labeling · Standard review | Approved | None posted |
| Dec 19, 2022 | Supplement 27Labeling · Standard review | Approved | None posted |
| Dec 17, 2020 | Supplement 21Labeling · Standard review | Approved | None posted |
| Dec 17, 2020 | Supplement 24Labeling · Standard review | Approved | None posted |
| Jul 28, 2015 | Supplement 18Labeling · Standard review | Approved | None posted |
| Jul 28, 2015 | Supplement 20Labeling · Standard review | Approved | None posted |
| May 19, 2010 | Supplement 17Labeling | Approved | None posted |
| Jun 3, 2009 | Supplement 16Labeling | Approved | None posted |
| Jun 27, 2007 | Supplement 13Labeling | Approved | None posted |
| Jul 24, 2006 | Supplement 11Labeling | Approved | None posted |
| Jul 24, 2006 | Supplement 12Labeling | Approved | None posted |
| Jul 8, 2005 | Supplement 10Labeling | Approved | None posted |
| Oct 20, 2004 | Supplement 6Labeling | Approved | None posted |
| May 14, 2004 | Supplement 5Labeling | Approved | None posted |
| Feb 20, 2004 | Supplement 4Labeling | Approved | None posted |
| Jan 14, 2003 | Supplement 2Labeling | Approved | None posted |
| Nov 27, 2002 | Supplement 1Manufacturing | Approved | None posted |
| May 7, 2001 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters